Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: FII75TFH5L

Physicochemical Descriptors

Property Name Value
Molecular Formula C16H16N8O
Molecular Weight 336.36
AlogP 1.41
Hydrogen Bond Acceptor 7.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 3.0
Polar Surface Area 112.58
Molecular species None
Aromatic Rings 3.0
Heavy Atoms 25.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR DNA-dependent protein kinase inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials
Carcinoma, Squamous Cell 1 D002294 ClinicalTrials
Glioblastoma 1 D005909 ClinicalTrials
Osteosarcoma 1 D012516 ClinicalTrials
Neoplasm Metastasis 1 D009362 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1228013-15-7
ChEMBL CHEMBL3545426
FDA SRS FII75TFH5L
PubChem 58298318